Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Cardiac Science Corporation:
Cardiac Science Corporation:
We consent to the use of our report dated March 15, 2010, with respect to the consolidated balance sheets of Cardiac Science Corporation as of December 31, 2009 and 2008, and the related consolidated statements of operations, equity and comprehensive income (loss), and cash flows for each of the years in the three-year period ended December 31, 2009, the related financial statement schedule II, and the effectiveness of internal control over financial reporting as of December 31, 2009, incorporated by reference herein and to the reference to our firm under the heading “Experts” in the prospectus. Our report refers to a change in accounting policy for minority interests as required by Statement of Financial Account Standards No. 160, “Noncontrolling Interests in Consolidated Financial Statements – an amendment of ARB No. 51” (included in FASB ASC Topic 810, “Consolidation”), effective January 1, 2009.
/s/ KPMG LLP
Seattle, Washington
May 7, 2010
Seattle, Washington
May 7, 2010